From: A phenome-guided drug repositioning through a latent variable model
Findings supported by drug labels | |||
---|---|---|---|
Drug | Indication | Rank | Reference |
Thioridazine | Schizophrenia | 1 | DB00679 |
Mesoridazine | Schizophrenia | 1 | DB00933 |
Bromazepam | Insomnia | 4 | DB01558 |
Nitrazepam | Insomnia | 3 | DB01595 |
Pipotiazine | Schizophrenia | 1 | DB01621 |
Nilotinib | Leukemia | 6 | DB04868 |
Findings supported by literature | |||
Drug | Indication | Rank | Reference |
Apomorphine | Anxiety | 6 | [25] |
Metyrapone | Cancer | 6 | [26] |
Prilocaine | Analgesia | 3 | [27] |
Sevoflurane | Sedation | 1 | [28] |
Remifentanil | Sedation | 1 | [29] |
Methohexital | Muscle relaxation | 2 | [30] |
Isoflurane | Sedation | 3 | [31] |
Disulfiram | Ulcer | 1 | [32] |